title: Letter in response to Levonorgestrel-releasing intrauterine system (Mirena®) and Depot medroxyprogesterone acetate (Depo-Provera) as long-term maintenance therapy for patients with moderate and severe endometriosis: a randomised trial by Wong AYK, Tang LCH, Chin RKH Aust N Z J Obstet Gynaecol 2010; 50 (3): 273-279.
authors.forename: Abhijit
authors.initials: A
authors.lastname: Basu
authors.forename: Mano
authors.initials: M
authors.lastname: Haran
authors.forename: Anil
authors.initials: A
authors.lastname: Nair
mesh_terms: D003271:Contraceptive Agents, Female / Q000627:therapeutic use; D004715:Endometriosis / Q000188:drug therapy* / Q000601:surgery; D005260:Female; D006801:Humans; D016912:Levonorgestrel / Q000627:therapeutic use*; D017258:Medroxyprogesterone Acetate / Q000627:therapeutic use*; D016032:Randomized Controlled Trials as Topic; D012720:Severity of Illness Index
chemical_list: D003271:Contraceptive Agents, Female; D016912:Levonorgestrel; D017258:Medroxyprogesterone Acetate